MedPath

Ayurveda regimen on quality of life among elderly population in Ballabhgarh.

Phase 2/3
Recruiting
Conditions
quality of life
Registration Number
CTRI/2023/01/049188
Lead Sponsor
Central Council for Research In Ayurveda Sciences
Brief Summary

| | |

| --- | --- |

|This project targets the geriatric age group and intends to assess the effect of Rasayana on the process of ageing. The outcome measures taken before, during, and at the conclusion of an intervention could be used to estimate how the approach/ intervention might change the rate of age-dependent deterioration in system integrity. It will provide leads in curbing deterioration in the physical activity, social outlook and cognitive functions of the geriatric population. This is an exploratory study and the selected ayurveda regimen will be implemented in community first time.

| |

| --- |

| The study will be carried outin apparently healthy elderly of age 60 years or more after obtaining theirconsent. The screening will be carried out based on the inclusion criteria inthe community of  Ballabhgarh Districtof  Haryana. The enrolled participants willbe administered the treatment modality for a run-in period of three monthsfollowing which they will be divided into responders and non-responders. Onlyresponders will be recruited for the actual interventional study

Study Type- Series of N of 1 responder restricted design. Purpose-Impact assessment on quality of life in geriatric population.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Clinically stable participants who have completed 60 years of age of either gender (Screening assessments for clinically stable participants will be done on the basis of medical history, physical examination, safety laboratory tests (CBC, ESR, LFT, RFT, FBS, PPBS, Lipid profile, VDRL), vital signs, ECG, X-ray) 2.
  • Participants should be in generally good health and those with chronic diseases should be (hypertension, coronary artery disease, etc.) clinically stable with medication and should not affect the day to day activities.
  • Participants fit enough to participate and qualify in the assessment tests while screening.
  • Participants who will voluntarily give consent to participate and comply to the trial interventions strictly for 9 months.
Exclusion Criteria
  • Participants with major systemic illness including liver disease, kidney diseases, and malignancy.
  • Cardiovascular diseases (unstable ischemic heart disease, etc) or uncontrolled blood pressure (>180/110 mmHg) 3.
  • Uncontrolled Diabetes Mellitus (HbA1C > 8%) 4.
  • Cognitive impairment, neuro-psychiatric diseases which would render the participants unable to participate in the assessment tests.
  • Participant taking participation in any other clinical trial.
  • Any other condition that the Principle investigator thinks may jeopardize the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
different time lines0 months 3 months 5 months 7 months 9 months
Change in quality of life in terms of Old peoples0 months 3 months 5 months 7 months 9 months
Quality Of Life (OPQOL)0 months 3 months 5 months 7 months 9 months
Questionnaire at five0 months 3 months 5 months 7 months 9 months
This is score based and has been used for sample size calculation.0 months 3 months 5 months 7 months 9 months
Secondary Outcome Measures
NameTimeMethod
1. Change in various haematological andbiochemical, radiological parameters

Trial Locations

Locations (1)

PHC, ballabhgarh, AIIMS, New Delhi

🇮🇳

Faridabad, HARYANA, India

PHC, ballabhgarh, AIIMS, New Delhi
🇮🇳Faridabad, HARYANA, India
Dr Puneet Misra
Principal investigator
011-26593773
doctormisra@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.